Horowitz, J R <br/><br/>
Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium.  [electronic resource] 

 -  Arteriosclerosis, thrombosis, and vascular biology  Nov 1997 
 - 2793-800 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1079-5642 
<br/><br/><label>Standard No.: </label>10.1161/01.atv.17.11.2793  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Aorta--drug effects<br/>Cholesterol, Dietary--toxicity<br/>Diet, Atherogenic<br/>Echocardiography<br/>Endothelial Growth Factors--pharmacology<br/>Endothelium, Vascular--metabolism<br/>Enzyme Inhibitors--pharmacology<br/>Hemodynamics--drug effects<br/>Humans<br/>Hypercholesterolemia--etiology<br/>Hypotension--chemically induced<br/>Lymphokines--pharmacology<br/>Nitric Oxide--physiology<br/>Nitric Oxide Synthase--antagonists & inhibitors<br/>Nitroarginine--pharmacology<br/>Rabbits<br/>Receptor Protein-Tyrosine Kinases--drug effects<br/>Receptors, Growth Factor--drug effects<br/>Receptors, Vascular Endothelial Growth Factor<br/>Recombinant Proteins--pharmacology<br/>Secretory Rate--drug effects<br/>Swine<br/>Vascular Endothelial Growth Factor A<br/>Vascular Endothelial Growth Factors<br/>Vasodilation--drug effects<br/>omega-N-Methylarginine--pharmacology